|
Video: What is a Stock Split?
|
|
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing the treatment of GI diseases. Co. is focused on the development and commercialization of GI product opportunities. LINZESS® (linaclotide), Co.'s commercial product, is a product approved by the U.S. Food and Drug Administration in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation. Co. is also developing IW-3300, a GC-C agonist, for the potential treatment of visceral pain conditions, including interstitial cystitis / bladder pain syndrome and endometriosis. According to our IRWD split history records, Ironwood Pharmaceuticals has had 1 split. | |
|
Ironwood Pharmaceuticals (IRWD) has 1 split in our IRWD split history database. The split for IRWD took place on April 02, 2019. This was a 1194 for 1000 split, meaning for each 1000 shares of IRWD owned pre-split, the shareholder now owned 1194 shares. For example, a 1000 share position pre-split, became a 1194 share position following the split.
When a company such as Ironwood Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the IRWD split history from start to finish, an original position size of 1000 shares would have turned into 1194 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ironwood Pharmaceuticals shares, starting with a $10,000 purchase of IRWD, presented on a split-history-adjusted basis factoring in the complete IRWD split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
04/23/2024 |
|
Start price/share: |
$8.94 |
|
End price/share: |
$8.31 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-7.05% |
|
Average Annual Total Return: |
-0.73% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,293.33 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
04/02/2019 | 1194 for 1000 |
|
|